Mometasone Furoate Monohydrate

API Product
Mometasone Furoate Monohydrate | Hovione
Product Status:
Commercial
Available Grades:
  • Inhalation
Regulatory Status:
CN DMF
JP DMF
US DMF
CEP
Production Sites:
  • Hovione Loures
Product Type:
  • Corticosteroids
CAS Number:
141646-00-6
Modes of Application:
  • Inhalation
  • Nasal
Common Indications:
  • Allergic rhinitis
  • Asthma
Last Inspection:
FDA May 2018

Hovione can customize Mometasone Monohydrate API for nasal suspensions or inhalation based on its experience in particle size reduction technologies with tailored made, highly reproducible particle size distributions.

High crystalline purity, low amorphous content with prolonged stability are also part of our offering.

Hovione Mometasone Monohydrate API is available since 2008 and is approved in generic applications.

 

 

 


This is not to be construed as a representation of non-infringement or as an offer to sell in those countries where such would constitute an infringement of third parties' patent rights.

Highlight

Contact Us

Please contact us if you have inquiries about our offering

https://go.hovione.com/l/47122/2014-08-06/9grc

Related files

Hovione - Integrated Product List.pdf
pdf (3.28 MB)
Download

Related Content

Hovione Policies

Hovione is dedicated to serving the Pharma Industry by providing services and products that save human lives and improve quality of life. Our team is fully committed to our Quality, HSEEn, HR and Innovation & Entrepreneurship policies.

Page
Read more

Particle Engineering for Inhalation and Nasal

Hovione is a global expert and recognized leader in particle engineering, an essential technology when developing inhalation drug products.

Page
Read more

Inspections History

Hovione sites are periodically inspected by the local and external authorities. All sites are FDA approved and with exception of New Jersey site all have EU GMP certificates.

Page
Read more